COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS

COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS

Aim: to provide a literature review of the presently available data on the risk of thromboembolic events and current options for antithrombotic prophylaxis in patients with myeloproliferative neoplasms (MPN) patients with concomitant coronavirus disease 2019 (COVID-19). Material and methods. The...

Full description

Bibliographic Details
Main Authors:	O.M. Kostiukevych, L.K. Benkovska, A.M. Kravchenko, T.Ya. Chursina, K.O. Mikhaliev
Format:	Article
Language:	English
Published:	State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department 2022-10-01
Series:	Клінічна та профілактична медицина
Subjects:	sars-cov-2 infection coronavirus disease 2019 (covid-19) myeloproliferative neoplasms thrombosis antithrombotic prophylaxis antithrombotic therapy
Online Access:	https://cp-medical.com/index.php/journal/article/view/236

Similar Items

Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment
by: Tiziano Barbui, et al.
Published: (2022-01-01)

Does antithrombotic prophylaxis worsen early outcomes of total thyroidectomy? - a retrospective cohort study
by: E. Erdas, et al.
Published: (2019-04-01)

Investigation of Antithrombotic Drug Effects on Preventing Thrombosis Emerging in Gluteus Maximus Flaps before Anastomosis
by: Ertem K, et al.
Published: (2012-06-01)

Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis
by: Filippo Migliorini, et al.
Published: (2024-01-01)

ANTITHROMBOTIC PROPHYLAXIS RECURRENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
by: E. V. Zhuravleva, et al.
Published: (2016-06-01)

Antithrombotic effect of repeated doses of the ethanolic extract of local olive (Olea europaea L.) leaves in rabbits
by: Abdallah M. Dub, et al.
Published: (2013-05-01)

ANTITHROMBOTIC PROPHYLAXIS REPEATED PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
by: E. V. Zhuravleva
Published: (2016-06-01)

Comparative antiplatelet and antithrombotic effects of red ginseng and fermented red ginseng extracts
by: Muhammad Irfan, et al.
Published: (2022-05-01)

Antithrombotic potential of Berberis calliobotrys extract
by: . Alamgeer, et al.
Published: (2016-10-01)

In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata)
by: L. Cardilo-Reis, et al.
Published: (2006-11-01)

Editorial: Antithrombotic Prophylaxis in Patients With Atrial Fibrillation for Stroke Prevention: Evidence From Randomized Clinical Trials, Observational Studies, Methodological Modeling, and More
by: Junguo Zhang, et al.
Published: (2021-02-01)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
by: Yutao Guo, et al.
Published: (2010-05-01)

Management of Patients on Antithrombotic Agents Undergoing Endoscopy
by: Joon Sung Kim, et al.
Published: (2018-05-01)

Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells
by: H.B. Nader, et al.
Published: (2001-06-01)

Optimal Antithrombotic Strategies in Cardiogenic Shock
by: Michal Droppa, et al.
Published: (2024-01-01)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
by: Laurent Derex, et al.
Published: (2018-01-01)

Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence
by: Alberto Palazzuoli, et al.
Published: (2021-04-01)

Bleeding risk and mortality according to antithrombotic agents’ exposure in cancer-related stroke patients: nationwide population-based cohort study in South Korea
by: Bo Kyu Choi, et al.
Published: (2023-05-01)

ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY
by: A. V. Khromylev, et al.
Published: (2016-10-01)

Is the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage?<subtitle>It Depends</subtitle>
by: Jose Gutierrez
Published: (2021-03-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Ischemic stroke and antithrombotic therapy: key aspects
by: M. Yu. Maksimova, et al.
Published: (2019-12-01)

Antithrombotic Therapy in Patients with Prosthetic Heart Valves
by: Mohamed HA
Published: (2009-01-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

Mechanisms of attenuation of clot formation and acute thromboembolism by syringic acid in mice
by: Jun-Hui Choi, et al.
Published: (2018-04-01)

THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL
by: I. V. Gribkova, et al.
Published: (2017-12-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

Current Guidelines on Antithrombotic Management in Patients Undergoing Gastrointestinal Endoscopy
by: Muhammad Begawan Bestari, et al.
Published: (2019-05-01)

The safety of in‐office laryngologic procedures during active antithrombotic therapy
by: Jeffrey M. Straub, et al.
Published: (2020-10-01)

Antithrombotic treatment in COVID-19 – from theory to practical approach
by: Ionela-Larisa Miftode, et al.
Published: (2021-09-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)

Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention
by: Hangkuan Liu, et al.
Published: (2021-01-01)

Stroke, coronary and peripheral artery disease survey on antithrombotic treatment (START IT)
by: C Warncke
Published: (2010-03-01)

Thrombosis in patients with myeloproliferative neoplasms. Case report
by: Anait L. Melikyan, et al.
Published: (2021-07-01)

The Antithrombotic Effect of Recombinant Neorudin on Thrombi
by: Liu YB, et al.
Published: (2022-06-01)

New Antithrombotic Drugs in Acute Coronary Syndrome
by: Bastiaan Zwart, et al.
Published: (2020-06-01)

Gastrointestinal Endoscopy in Patients Receiving Antithrombotic Therapy
by: Supriadi Supriadi, et al.
Published: (2021-09-01)

ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE
by: A. V. Fonyakin
Published: (2009-06-01)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
by: Handoyo V, et al.
Published: (2019-02-01)